Evaluating the Role of LPIN1 Variation in Insulin Resistance, Body Weight, and Human Lipodystrophy in U.K. Populations

Overview

Journal Diabetes

Specialty Endocrinology

Date 2008 Jul 2

PMID 18591397

Citations 23

Authors

Katherine A Fawcett

Neil Grimsey

Ruth J F Loos

Eleanor Wheeler

Allan Daly

Maria Soos

Robert Semple

Holly Syddall

Cyrus Cooper

Symeon Siniossoglou

Stephen ORahilly

Nicholas J Wareham

Ines Barroso

Affiliations

Soon will be listed here.

Abstract

Objective: Loss of lipin 1 activity causes lipodystrophy and insulin resistance in the fld mouse, and LPIN1 expression and common genetic variation were recently suggested to influence adiposity and insulin sensitivity in humans. We aimed to conduct a comprehensive association study to clarify the influence of common LPIN1 variation on adiposity and insulin sensitivity in U.K. populations and to examine the role of LPIN1 mutations in insulin resistance syndromes.

Research Design And Method: Twenty-two single nucleotide polymorphisms tagging common LPIN1 variation were genotyped in Medical Research Council (MRC) Ely (n = 1,709) and Hertfordshire (n = 2,901) population-based cohorts. LPIN1 exons, exon/intron boundaries, and 3' untranslated region were sequenced in 158 patients with idiopathic severe insulin resistance (including 23 lipodystrophic patients) and 48 control subjects.

Results: We found no association between LPIN1 single nucleotide polymorphisms and fasting insulin but report a nominal association between rs13412852 and BMI (P = 0.042) in a meta-analysis of 8,504 samples from in-house and publicly available studies. Three rare nonsynonymous variants (A353T, R552K, and G582R) were detected in severely insulin-resistant patients. However, these did not cosegregate with disease in affected families, and Lipin1 protein expression and phosphorylation in patients with variants were indistinguishable from those in control subjects.

Conclusions: Our data do not support a major effect of common LPIN1 variation on metabolic traits and suggest that mutations in LPIN1 are not a common cause of lipodystrophy in humans. The nominal associations with BMI and other metabolic traits in U.K. cohorts require replication in larger cohorts.

Citing Articles

Role of lipins in cardiovascular diseases.

Ding Z, Song H, Wang F Lipids Health Dis. 2023; 22(1):196.

PMID: 37964368 PMC: 10644651. DOI: 10.1186/s12944-023-01961-6.

Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?.

Singh S, Anirvan P, Khandelwal R, Satapathy S J Clin Transl Hepatol. 2021; 9(6):931-938.

PMID: 34966656 PMC: 8666378. DOI: 10.14218/JCTH.2021.00174.

Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy.

Villani R, Magnati G, De Girolamo G, Sangineto M, Romano A, Cassano T Front Med (Lausanne). 2021; 8:737759.

PMID: 34746177 PMC: 8566437. DOI: 10.3389/fmed.2021.737759.

Genetic and epigenetic factors determining NAFLD risk.

Jonas W, Schurmann A Mol Metab. 2020; 50:101111.

PMID: 33160101 PMC: 8324682. DOI: 10.1016/j.molmet.2020.101111.

Caenorhabditis elegans Lipin 1 moderates the lifespan-shortening effects of dietary glucose by maintaining ω-6 polyunsaturated fatty acids.

Jung Y, Kwon S, Ham S, Lee D, Park H, Yamaoka Y Aging Cell. 2020; 19(6):e13150.

PMID: 32475074 PMC: 7294780. DOI: 10.1111/acel.13150.

References

Santos-Rosa H, Leung J, Grimsey N, Peak-Chew S, Siniossoglou S . The yeast lipin Smp2 couples phospholipid biosynthesis to nuclear membrane growth. EMBO J. 2005; 24(11):1931-41. PMC: 1142606. DOI: 10.1038/sj.emboj.7600672. View

Cao H, Hegele R . Identification of single-nucleotide polymorphisms in the human LPIN1 gene. J Hum Genet. 2002; 47(7):370-2. DOI: 10.1007/s100380200052. View

Donkor J, Sparks L, Xie H, Smith S, Reue K . Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab. 2007; 93(1):233-9. PMC: 2190746. DOI: 10.1210/jc.2007-1535. View

Lindegaard B, Larsen L, Hansen A, Gerstoft J, Pedersen B, Reue K . Adipose tissue lipin expression levels distinguish HIV patients with and without lipodystrophy. Int J Obes (Lond). 2006; 31(3):449-56. DOI: 10.1038/sj.ijo.0803434. View

Croce M, Eagon J, LaRiviere L, Korenblat K, Klein S, Finck B . Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes. 2007; 56(9):2395-9. DOI: 10.2337/db07-0480. View

Cann H, De Toma C, Cazes L, Morel V, Piouffre L, Bodmer J . A human genome diversity cell line panel. Science. 2002; 296(5566):261-2. DOI: 10.1126/science.296.5566.261b. View

Xu J, Lee W, Phan J, Saad M, Reue K, Kurland I . Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes. 2006; 55(12):3429-38. DOI: 10.2337/db06-0260. View

Ekelund U, Franks P, Sharp S, Brage S, Wareham N . Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness. Diabetes Care. 2007; 30(8):2101-6. DOI: 10.2337/dc07-0719. View

de Bakker P, Yelensky R, Peer I, Gabriel S, Daly M, Altshuler D . Efficiency and power in genetic association studies. Nat Genet. 2005; 37(11):1217-23. DOI: 10.1038/ng1669. View

10.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M, Bender D . PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-75. PMC: 1950838. DOI: 10.1086/519795. View

11.

Phan J, Reue K . Lipin, a lipodystrophy and obesity gene. Cell Metab. 2005; 1(1):73-83. DOI: 10.1016/j.cmet.2004.12.002. View

12.

Yao-Borengasser A, Rasouli N, Varma V, Miles L, Phanavanh B, Starks T . Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes. 2006; 55(10):2811-8. DOI: 10.2337/db05-1688. View

13.

Tange Y, Hirata A, Niwa O . An evolutionarily conserved fission yeast protein, Ned1, implicated in normal nuclear morphology and chromosome stability, interacts with Dis3, Pim1/RCC1 and an essential nucleoporin. J Cell Sci. 2002; 115(Pt 22):4375-85. DOI: 10.1242/jcs.00135. View

14.

Suviolahti E, Reue K, Cantor R, Phan J, Gentile M, Naukkarinen J . Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum Mol Genet. 2005; 15(3):377-86. DOI: 10.1093/hmg/ddi448. View

15.

Peterfy M, Phan J, Xu P, Reue K . Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001; 27(1):121-4. DOI: 10.1038/83685. View

16.

Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N . Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004; 96(6):434-42. PMC: 7713993. DOI: 10.1093/jnci/djh075. View

17.

Day N, Oakes S, Luben R, Khaw K, Bingham S, Welch A . EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999; 80 Suppl 1:95-103. View

18.

Finck B, Gropler M, Chen Z, Leone T, Croce M, Harris T . Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006; 4(3):199-210. DOI: 10.1016/j.cmet.2006.08.005. View

19.

Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A . Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes. 2007; 57(1):209-17. DOI: 10.2337/db07-0083. View

20.

Loos R, Rankinen T, Perusse L, Tremblay A, Despres J, Bouchard C . Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring). 2007; 15(11):2723-32. DOI: 10.1038/oby.2007.324. View